×
For best experience we recommend to activate Javascript in your browser.
FGF8 antibody (N-Term)
This anti-FGF8 antibody is a Rabbit Polyclonal antibody detecting FGF8 in WB and ELISA. Suitable for Mouse.
Quick Overview for FGF8 antibody (N-Term) (ABIN2266614)
Target
See all FGF8 Antibodies
FGF8
(Fibroblast Growth Factor 8 (Androgen-Induced) (FGF8))
Reactivity
All reactivities for FGF8 antibodies
Mouse
Host
All hosts for FGF8 antibodies
Rabbit
Clonality
All clonalities for FGF8 antibodies
Polyclonal
Conjugate
All conjugates for FGF8 antibodies
This FGF8 antibody is un-conjugated
Application
All applications for FGF8 antibodies
Western Blotting (WB), ELISA
Product Details anti-FGF8 Antibody
(hide)
Binding Specificity
All epitopes for FGF8 antibodies
AA 30-59, N-Term
Cross-Reactivity
Mouse (Murine)
Cross-Reactivity (Details)
Calculated cross reactivity: Mo
Characteristics
Fgf8, NT (Fgf8, Aigf, Fibroblast growth factor 8, Androgen-induced growth factor, Heparin-binding growth factor 8)
Purification
Purified by Protein A affinity chromatography.
Immunogen
Mouse Fgf8 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 30-59 amino acids from the N-terminal region of mouse Fgf8.
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working conditions should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
-20°C
Target Details for FGF8
(hide)
Target
FGF8
(Fibroblast Growth Factor 8 (Androgen-Induced) (FGF8))
Alternative Name
Fgf8
NCBI Accession
NP_001159834
UniProt
P37237
Pathways
RTK Signaling , Fc-epsilon Receptor Signaling Pathway , EGFR Signaling Pathway , Neurotrophin Signaling Pathway , Dopaminergic Neurogenesis
Recently viewed
(hide)
Chat with us , powered by LiveChat